Astrazeneca Share Discussion Threads

[mac15] 24/7/2024 18:32

Hope so. I have a £490k stake built up since 2009. Hope to hit the million mark fairly soon. Great co and CEO!

[philanderer] 24/7/2024 13:32

Results tomorrow.

[blackhorse23] 28/6/2024 10:46

Switched to RNK [better change to capital gains] 4 brokers issued strong BUY

[blackhorse23] 12/6/2024 09:22

Money moved to APH [Alliance Pharma]

[c3479z] 11/6/2024 11:34

aph quality poor, nowhere near the same outfit as eg AZN

[blackhorse23] 06/6/2024 15:19

They raised APH ( alliance Pharma ) to BUY as well

[philanderer] 05/6/2024 09:12

HSBC raises AstraZeneca price target to 14,070 (12,950) pence - 'buy'

[philanderer] 30/5/2024 09:27

Goldman starts AstraZeneca with 'buy' - price target 15,200 pence

[holts] 23/5/2024 19:22

Meanwhile Nvidia rises as much in a day as Astras market value , nuts .

[philanderer] 22/5/2024 10:27

Stifel raises AstraZeneca price target to 13,700 (12,800) pence - 'buy'

[blackhorse23] 13/5/2024 09:11

Money moved to APH ( alliance Pharma )

[1knocker] 11/5/2024 21:31

Getting close to time to sell, and buy back cheaper?

[diku] 11/5/2024 20:56

RSI looking grossly over bought...

[kasg] 08/5/2024 21:17

BBC News - AstraZeneca to withdraw Covid vaccinehttps://www.bbc.co.uk/news/health-68977026

[gregb] 08/5/2024 19:35

Most big pharma have GLP-1 agonists on trial. Let's hope AZN's has the least side effects!

[smcni1968] 08/5/2024 16:23

Astra have a little obesity pill that they'll be putting out the phase one results for soon. And at least one other obesity project. I think the plan is to combine the pill with other drugs to treat medical conditions and also sell a cheap version for cosmetic weight loss.

[hotfinance14] 08/5/2024 05:24

Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Berenberg expects Astrazeneca to state a new revenue ambition at its 21 May investor day, highlighting confidence in growth to 2030 from already visible assets. High single-digit growth would equate to a roughly $75.0bn-80.0bn top line and approximately 20% upside to consensus, it noted.

"On our estimates, global large pharma is on track to grow sales at 4% pa for 2026-30 (range -2% to 13%) with an average 2025 P/E of 16.6x (range 7-42x). High single-digit growth would put Astrazeneca at the top end of the non-obesity range and warrant a multiple above 20x, in our view," said Berenberg.

The German bank stated it was raising its price target to reflect "recent, positive pipeline updates", which implies a 2025 price-to-earnings ratio of 19x.

"We reiterate our 'buy' recommendation as positive pipeline momentum through to 2025 has the potential to unlock sales upgrades and share price upside," said Berenberg.

"Astrazeneca offers top-tier sales growth at an attractive valuation, with a P/E of 17.4x 2025E versus an EU sector average of 15.7x and EV/NPV of 1.05x versus an average of 1.01x"

[philanderer] 07/5/2024 12:06

Berenberg raises AstraZeneca price target to 13,000 (12,000) pence - 'buy'

[blackhorse23] 03/5/2024 09:53

Money moving to APH AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders-DIVIDEND +5% -PORTFOLIO BROADENED THROUGH ACQUISITION

[philanderer] 25/4/2024 15:10

AstraZeneca overtakes Shell as Britain’s most valuable company

[holts] 25/4/2024 09:03

Quality advice from Deutsche Bank :-)

[beckers2008] 25/4/2024 08:44

So glad I dipped in at £97.70.7 a few weeks ago.
Good results from a solid company.

[harry_david] 25/4/2024 07:41

Mr buywell, I hope you are fully recovered from your bout of alzheimers and enjoying the set of great results today